{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T20:53:02Z","timestamp":1792011182848,"version":"4.4.0"},"reference-count":29,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Problems in Cardiology"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1016\/j.cpcardiol.2021.100958","type":"journal-article","created":{"date-parts":[[2021,8,4]],"date-time":"2021-08-04T02:41:03Z","timestamp":1628044863000},"page":"100958","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Rational, Design and Preliminary Results of a Cohort Study on Breast and Colorectal Cancer to Develop a Risk Assessment Model to Predict Future Cardiovascular Events. \u201cCardio Vascular Events in Breast and Colorectal Cancers (CIBC) Study\u201d"],"prefix":"10.1016","volume":"47","author":[{"given":"Kiyan","family":"Heshmat-Ghahdarijani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamshid","family":"Najafian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zamaneh","family":"Vafaei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samaneh","family":"Mostafavi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noushin","family":"Mohammadifard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marjan","family":"Mansourian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farzaneh","family":"Ashrafi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehran","family":"Sharifi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammadreza","family":"Khosravifarsani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Darakhshandeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emami","family":"Mohammad Hassan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javanmard","family":"Shaghayegh Haghjooy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nizal","family":"Sarrafzadegan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cpcardiol.2021.100958_bib0001","doi-asserted-by":"crossref","unstructured":"Siegel RL, Miller KD, Jemal A. Cancer statistics, 2015. CA Cancer J Clin. 2015;65:5-29.","DOI":"10.3322\/caac.21254"},{"key":"10.1016\/j.cpcardiol.2021.100958_bib0002","doi-asserted-by":"crossref","unstructured":"Roshandel G, Ghanbari-Motlagh A, Partovipour E, et al. Cancer incidence in Iran in 2014: Results of the Iranian National Population-based Cancer Registry. Cancer Epidemiol. 2019;61:50-58.","DOI":"10.1016\/j.canep.2019.05.009"},{"key":"10.1016\/j.cpcardiol.2021.100958_bib0003","doi-asserted-by":"crossref","unstructured":"Payne DL, Nohria A. Prevention of Chemotherapy Induced Cardiomyopathy. Current heart failure reports. 2017;14:398-403.","DOI":"10.1007\/s11897-017-0353-9"},{"key":"10.1016\/j.cpcardiol.2021.100958_bib0004","doi-asserted-by":"crossref","unstructured":"Hamo CE, Bloom MW, Cardinale D, et al. Cancer Therapy-Related Cardiac Dysfunction and Heart Failure: Part 2: Prevention, Treatment, Guidelines, and Future Directions. Circulation Heart failure. 2016;9:e002843.","DOI":"10.1161\/CIRCHEARTFAILURE.115.002843"},{"key":"10.1016\/j.cpcardiol.2021.100958_bib0005","doi-asserted-by":"crossref","unstructured":"Fanous I, Dillon P. Cancer treatment-related cardiac toxicity: prevention, assessment and management. Med Oncol (Northwood, London, England). 2016;33:84.","DOI":"10.1007\/s12032-016-0801-5"},{"key":"10.1016\/j.cpcardiol.2021.100958_bib0006","doi-asserted-by":"crossref","unstructured":"Thavendiranathan P, Nolan MT. An emerging epidemic: cancer and heart failure. Clin Sci (London, England: 1979). 2017;131:113-121.","DOI":"10.1042\/CS20160412"},{"key":"10.1016\/j.cpcardiol.2021.100958_bib0007","doi-asserted-by":"crossref","unstructured":"Narayan HK, Finkelman B, French B, et al. Detailed echocardiographic phenotyping in breast cancer patients: associations with ejection fraction decline, recovery, and heart failure symptoms over 3 years of follow-up. Circulation. 2017;135:1397-1412.","DOI":"10.1161\/CIRCULATIONAHA.116.023463"},{"key":"10.1016\/j.cpcardiol.2021.100958_bib0008","doi-asserted-by":"crossref","unstructured":"Cardinale D, Colombo A, Bacchiani G,et al.Early detection of anthracycline cardiotoxicity and improvement with heart failure therapy. Circulation. 2015;131:1981-1988.","DOI":"10.1161\/CIRCULATIONAHA.114.013777"},{"key":"10.1016\/j.cpcardiol.2021.100958_bib0009","doi-asserted-by":"crossref","unstructured":"Van der Pal HJ, van Dalen EC, Hauptmann M, et al. Cardiac function in 5-year survivors of childhood cancer: a long-term follow-up study. Arch Intern Med. 2010;170:1247-1255.","DOI":"10.1001\/archinternmed.2010.233"},{"key":"10.1016\/j.cpcardiol.2021.100958_bib0010","doi-asserted-by":"crossref","unstructured":"Bria E, Cuppone F, Fornier M, et al. Cardiotoxicity and incidence of brain metastases after adjuvant trastuzumab for early breast cancer: the dark side of the moon? A meta-analysis of the randomized trials. Breast Cancer Res Treat. 2008;109:231-239.","DOI":"10.1007\/s10549-007-9663-z"},{"key":"10.1016\/j.cpcardiol.2021.100958_bib0011","doi-asserted-by":"crossref","unstructured":"Park SM, Lim MK, Shin SA, et al. Impact of prediagnosis smoking, alcohol, obesity, and insulin resistance on survival in male cancer patients: National Health Insurance Corporation Study. J Clin Oncol. 2006;24:5017-5024.","DOI":"10.1200\/JCO.2006.07.0243"},{"key":"10.1016\/j.cpcardiol.2021.100958_bib0012","unstructured":"Mohammadifard N, Sajjadi F, Maghroun M, et al. Validation of a simplified food frequency questionnaire for the assessment of dietary habits in Iranian adults: Isfahan Healthy Heart Program, Iran. ARYA atherosclerosis. 2015;11:139."},{"key":"10.1016\/j.cpcardiol.2021.100958_bib0013","doi-asserted-by":"crossref","unstructured":"Montazeri A, Vahdaninia M, Ebrahimi M, et al. The Hospital Anxiety and Depression Scale (HADS): translation and validation study of the Iranian version. Health and quality of life outcomes. 2003;1:14.","DOI":"10.1186\/1477-7525-1-14"},{"key":"10.1016\/j.cpcardiol.2021.100958_bib0014","doi-asserted-by":"crossref","unstructured":"Nouri M, Ghaffarifar S, Sadeghi-Bazargani H. Development of the Persian patient satisfaction questionnaire. Int J Health Care Qual Assur. 2018;31:988-999.","DOI":"10.1108\/IJHCQA-06-2017-0101"},{"key":"10.1016\/j.cpcardiol.2021.100958_bib0015","doi-asserted-by":"crossref","unstructured":"Craig CL, Marshall AL, Sj\u00f6str\u00f6m M, et al. International physical activity questionnaire: 12-country reliability and validity. Med Sci Sports Exercise. 2003;35:1381-1395.","DOI":"10.1249\/01.MSS.0000078924.61453.FB"},{"key":"10.1016\/j.cpcardiol.2021.100958_bib0016","doi-asserted-by":"crossref","unstructured":"Sarrafzadegan N, Talaei M, Sadeghi M, et al. The Isfahan cohort study: rationale, methods and main findings. J Hum Hypertens. 2011;25:545.","DOI":"10.1038\/jhh.2010.99"},{"key":"10.1016\/j.cpcardiol.2021.100958_bib0017","doi-asserted-by":"crossref","unstructured":"Lang RM, Badano LP, Mor-Avi V, et al. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. European Heart Journal-Cardiovascular Imaging. 2015;16:233-271.","DOI":"10.1093\/ehjci\/jev014"},{"key":"10.1016\/j.cpcardiol.2021.100958_bib0018","doi-asserted-by":"crossref","unstructured":"Chobanian AV, Bakris GL, Black HR, et al. The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report. JAMA. 2003;289:2560-2571.","DOI":"10.1001\/jama.289.19.2560"},{"key":"10.1016\/j.cpcardiol.2021.100958_bib0019","doi-asserted-by":"crossref","unstructured":"Warnick GR, Benderson J, Albers JJ. Dextran sulfate-Mg2+ precipitation procedure for quantitation of high-density-lipoprotein cholesterol. Clin Chem. 1982;28:1379-1388.","DOI":"10.1093\/clinchem\/28.6.1379"},{"key":"10.1016\/j.cpcardiol.2021.100958_bib0020","doi-asserted-by":"crossref","unstructured":"Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972;18:499-502.","DOI":"10.1093\/clinchem\/18.6.499"},{"key":"10.1016\/j.cpcardiol.2021.100958_bib0021","doi-asserted-by":"crossref","unstructured":"Hedayati SS, Minhajuddin AT, Ijaz A, et al. Association of urinary sodium\/potassium ratio with blood pressure: sex and racial differences. Clinical journal of the American Society of Nephrology: CJASN. 2012;7:315-322.","DOI":"10.2215\/CJN.02060311"},{"key":"10.1016\/j.cpcardiol.2021.100958_bib0022","doi-asserted-by":"crossref","unstructured":"Narayan HK, French B, Khan AM, et al. Noninvasive measures of ventricular-arterial coupling and circumferential strain predict cancer therapeutics\u2013related cardiac dysfunction. JACC: Cardiovascular Imaging. 2016;9:1131-1141.","DOI":"10.1016\/j.jcmg.2015.11.024"},{"key":"10.1016\/j.cpcardiol.2021.100958_bib0023","doi-asserted-by":"crossref","unstructured":"Curigliano G, Cardinale D, Dent S, et al. Cardiotoxicity of anticancer treatments: epidemiology, detection, and management. CA: a cancer journal for clinicians. 2016;66:309-325.","DOI":"10.3322\/caac.21341"},{"key":"10.1016\/j.cpcardiol.2021.100958_bib0024","doi-asserted-by":"crossref","unstructured":"Ky B, French B, Khan AM, et al. Ventricular-arterial coupling, remodeling, and prognosis in chronic heart failure. J Am Coll Cardiol. 2013;62:1165-1172.","DOI":"10.1016\/j.jacc.2013.03.085"},{"key":"10.1016\/j.cpcardiol.2021.100958_bib0025","doi-asserted-by":"crossref","unstructured":"Alfieri O, Mayosi BM, Park S-J, et al. Exploring unknowns in cardiology. Nat Rev Cardiol. 2014;11:664-670.","DOI":"10.1038\/nrcardio.2014.123"},{"key":"10.1016\/j.cpcardiol.2021.100958_bib0026","doi-asserted-by":"crossref","unstructured":"Masoudkabir F, Sarrafzadegan N, Gotay C, et al. Cardiovascular disease and cancer: Evidence for shared disease pathways and pharmacologic prevention. Atherosclerosis. 2017;263:343-351.","DOI":"10.1016\/j.atherosclerosis.2017.06.001"},{"key":"10.1016\/j.cpcardiol.2021.100958_bib0027","doi-asserted-by":"crossref","unstructured":"Ezaz G, Long JB, Gross CP, et al. Risk prediction model for heart failure and cardiomyopathy after adjuvant trastuzumab therapy for breast cancer. J Am Heart Assoc. 2014;3:e000472.","DOI":"10.1161\/JAHA.113.000472"},{"key":"10.1016\/j.cpcardiol.2021.100958_bib0028","doi-asserted-by":"crossref","unstructured":"Piccart-Gebhart MJ, Procter M, Leyland-Jones B, et al. Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer. N Engl J Med. 2005;353:1659-1672.","DOI":"10.1056\/NEJMoa052306"},{"key":"10.1016\/j.cpcardiol.2021.100958_bib0029","doi-asserted-by":"crossref","unstructured":"Slamon D, Eiermann W, Robert N, et al. Adjuvant trastuzumab in HER2-positive breast cancer. N Engl J Med. 2011;365:1273-1283.","DOI":"10.1056\/NEJMoa0910383"}],"container-title":["Current Problems in Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0146280621001730?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0146280621001730?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T02:00:09Z","timestamp":1758938409000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0146280621001730"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":29,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2022,10]]}},"alternative-id":["S0146280621001730"],"URL":"https:\/\/doi.org\/10.1016\/j.cpcardiol.2021.100958","relation":{},"ISSN":["0146-2806"],"issn-type":[{"value":"0146-2806","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rational, Design and Preliminary Results of a Cohort Study on Breast and Colorectal Cancer to Develop a Risk Assessment Model to Predict Future Cardiovascular Events. \u201cCardio Vascular Events in Breast and Colorectal Cancers (CIBC) Study\u201d","name":"articletitle","label":"Article Title"},{"value":"Current Problems in Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cpcardiol.2021.100958","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"name":"copyright","label":"Copyright"}],"article-number":"100958"}}